Nurse Practitioner, Family · Bangor, ME
NPI
1518114222
Since 2008
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
900 Broadway
Bangor, ME, 04401
Phone (207) 907-1187
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
500 services
Medicare patients, 2024
151
Average age 70
Drug cost, 2024
$3.3M
4,518 prescriptions
Company payments, 2025
$344
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sheryl Sparlin was code 99215 (office e&m - established), 252 times for 130 patients. In total Sheryl Sparlin billed 500 services in 8 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 252 | 130 | $87.91 | $22K |
| 95251 Test - Miscellaneous | Office | 144 | 83 | $23.34 | $3,361 |
| 99214 Office E&M - Established | Office | 49 | 43 | $56.14 | $2,751 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 45 | 45 | $11.10 | $500 |
By year: 2022 $29K for 564 services; 2023 $29K for 497 services; 2024 $29K for 500 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sheryl Sparlin prescribed most often to Medicare patients was Trulicity (Dulaglutide), with 465 prescriptions and refills. In total Sheryl Sparlin wrote 4,518 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | 465 | 696 | 90 | $680K |
| Glipizide Generic | 342 | 816 | 99 | $3,395 |
| Metformin Hcl Er Metformin Hcl | 340 | 846 | 96 | $4,670 |
| Jardiance Empagliflozin | 285 | 648 | 68 | $372K |
| Ozempic Semaglutide | 199 | 336 | 46 | $315K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 191 | 410 | 63 | $49K |
| Novolog Flexpen Insulin Aspart | 186 | 409 | 74 | $80K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 184 | 476 | 81 | $27K |
| Tresiba Flextouch U-100 Insulin Degludec | 173 | 430 | 60 | $174K |
| Tresiba Flextouch U-200 Insulin Degludec | 153 | 363 | 50 | $362K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 114 | 251 | 34 | $72K |
| Farxiga Dapagliflozin Propanediol | 110 | 233 | 25 | $126K |
| Humalog Kwikpen U-100 Insulin Lispro | 100 | 211 | 36 | $44K |
| Mounjaro Tirzepatide | 98 | 112 | 13 | $114K |
| Metformin Hcl Generic | 96 | 230 | 25 | $634 |
Brand drugs: 3,029 claims; generic drugs: 871 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sheryl Sparlin $344 ($344 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $129.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.